Article

pacbiztimes.com on 2018-05-18 01:48

Amgen gets FDA approval for migraine drug Aimovig

Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 17 for its new monthly migraine treatment Aimovig.

Related news